MSD Partners, L.P. - Q4 2020 holdings

$598 Million is the total value of MSD Partners, L.P.'s 39 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 100.0% .

 Value Shares↓ Weighting
ExitNABRIVA THERAPEUTICS PLC$0-50,000
-100.0%
-0.01%
BMRGWS ExitB RILEY PRIN MERGER CORP II*w exp 05/06/202$0-350,000
-100.0%
-0.10%
SUN ExitSUNOCO LP/SUNOCO FIN CORP$0-204,167
-100.0%
-1.04%
BMRG ExitB RILEY PRIN MERGER CORP IIcl a$0-531,820
-100.0%
-1.11%
DGNRU ExitDRAGONEER GROWTH OPPORTUN COunit 08/18/2027$0-875,000
-100.0%
-2.24%
CIT ExitCIT GROUP INC$0-671,000
-100.0%
-2.49%
NGHC ExitNATIONAL GEN HLDGS CORP$0-2,162,500
-100.0%
-15.28%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ZIOPHARM ONCOLOGY INC42Q3 202315.7%
JPMORGAN CHASE & CO42Q3 20232.3%
STEALTHGAS INC39Q3 20232.8%
COOPER STD HLDGS INC29Q2 20223.0%
CITIGROUP INC28Q3 20231.4%
NATIONAL GEN HLDGS CORP26Q3 202015.3%
MARTEN TRANS LTD26Q3 20191.1%
SYNTHETIC BIOLOGICS INC21Q2 20180.5%
COTY INC20Q4 20187.4%
BLUEKNIGHT ENERGY PARTNERS L19Q4 20171.7%

View MSD Partners, L.P.'s complete holdings history.

Latest significant ownerships (13-D/G)

View MSD Partners, L.P.'s complete significant-ownership history.

Latest filings
TypeFiled
42024-06-05
13F-HR2024-05-15
40-APP2024-04-11
42024-03-08
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13

View MSD Partners, L.P.'s complete filings history.

Compare quarters

Export MSD Partners, L.P.'s holdings